The discovery of high-quality antibodies is critical for both research and therapeutic development. However, identifying rare antibody-secreting cells from B cell or hybridoma populations remains challenging, slowing the discovery process and increasing the risk of missing valuable antibody candidates.
This webinar will explore how integrating advanced screening technologies can overcome these bottlenecks.
Watch this webinar to learn how you can accelerate hit selection, improve functional screening, and enable the development of next-generation antibody discovery and screening pipelines by:
Sorting and functionally characterizing thousands of individual antibody-producing cells in one consumable
Identifying even rare producing cells, enabling downstream screening of only the best candidates
Isolating the top antibody-producing cells, facilitating more efficient selection of high-value lines
Play Video
